December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional World ex U.S. Core Equity 2 ETF (NY:DFAX)

33.03 +0.30 (+0.93%)
Streaming Delayed Price Updated: 1:07 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dimensional World ex U.S. Core Equity 2 ETF

< Previous 1 2 Next >
Tilray Stock On Track For Near 2-Month High As 'Weednesday' Buzz Builds Around Trump Cannabis Order — Retail Eyes Massive Upside ↗
Via Stocktwits
Topics Cannabis Government
News headline image
Stellantis CEO Says New Engine, Vehicle Models Will Drive ‘Progressively Better’ Demand ↗
Filosa said that the company is on track on its full year guidance through the end of November. 
Via Stocktwits
Topics Government World Trade
News headline image
Li Auto Posts Unexpected Loss In Q3 As EV Sales Drop ↗
CEO Xiang Li highlighted challenges pertaining to the supply chain and product lifecycle, among others. 
Via Stocktwits
Topics Economy
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study ↗
Via Stocktwits
BABA Stock Rises Pre-Market As AI-Driven Cloud Growth Drives Revenue Beat ↗
Via Stocktwits
News headline image
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies ↗
The company said that it is discontinuing the trials. 
Via Stocktwits
Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic ↗
Via Stocktwits
Toyota Commits Up To $10B Additional Investments In US Over Five Years ↗
Via Stocktwits
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence ↗
Via Stocktwits
Takeda Pharmaceuticals’ Genetic Disease Therapy Under FDA Probe After Pediatric Patient Dies ↗
The death of a pediatric congenital thrombotic thrombocytopenic purpura patient appears to be related to Adzynma, the FDA said. 
Via Stocktwits
News headline image
Novo Nordisk Brings Back Former CEO To Lead Board ↗
Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday. 
Via Stocktwits
News headline image
Stellantis NV Recalls Over 320,000 Jeep Plug-In Hybrids In US Over Fire Risk ↗
The recall includes certain model year 2020- 2025 Jeep Wrangler 4Xe and model year 2022-2026 Grand Cherokee 4Xe plug-in hybrid vehicles. 
Via Stocktwits
Topics Product Recall
News headline image
Alibaba’s AI Glasses To Be Priced At $659, Pre-Sale On October 24 On Its E-commerce Platform Tmall: Report ↗
According to a CNBC report, the price of the product, known as Quark AI Glasses, during pre-sale would be 4,699 yuan. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
AstraZeneca Unveils Expanded Facility In Texas Aimed At Doubling Production Of Hyperkalemia Drug ↗
The facility in Coppell, which employs more than 250 people, is the sole global manufacturing facility for the company’s Lokelma. 
Via Stocktwits
AstraZeneca Announces $4.5B Investment In Virginia ↗
Via Stocktwits
AstraZeneca Plans Ordinary Share Listing In US – Find Out More On The Harmonized Listing Structure ↗
Via Stocktwits
US Regulator Closes Probe Into Stellantis’ 24,000 Alfa Romeo Giulia Vehicles ↗
Via Stocktwits
US FDA Alleges Novo Nordisk’s Video On Weight-loss Drugs Featuring Oprah Winfrey Is ‘False Or Misleading’ ↗
Via Stocktwits
Novo Nordisk Says New Obesity Treatment Achieved 11.8% Body Weight Reduction In Late-stage Study ↗
Via Stocktwits
Stellantis Recalls Nearly 54,000 Vehicles In US Over Concerns Regarding Fuel Pump: But Retail Sees Stock Rallying To $10 This Week ↗
Via Stocktwits
Topics Product Recall
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report ↗
Via Stocktwits
Toyota Recalls Over Half A Million Vehicles In The US ↗
Via Stocktwits
Topics Product Recall
Ford Supplier Magna International Appoints Former Timken Executive As CFO ↗
Via Stocktwits
Topics Supply Chain
Stellantis Stock Slips After US Regulator Probes 287,000 Chrysler Minivans Over Concerns Regarding Electric Power Steer ↗
Via Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More ↗
Via Stocktwits
Citi Lowers Price Target On This Chinese EV Maker After Disappointing Q3 Guidance: Retail Expects Shares To ‘Eventually Implode’ ↗
Via Stocktwits
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More ↗
Via Stocktwits
Stellantis Shells Out $41M More To Expand Its U.S. Parts Distribution Network: More Details Inside ↗
Via Stocktwits
News headline image
Li Auto Announces Lower Q3 Delivery Outlook Despite New Vehicle Launches: Retail Sees i8, i6 Selling Like ‘Hot Cakes’ ↗
Li Auto now expects vehicle deliveries to be between 90,000 and 95,000 vehicles, representing a year-over-year decrease of 41.1% to 37.8%. 
Via Stocktwits
Topics Earnings
News headline image
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today? ↗
Novo Nordisk has entered into a collaboration with Replicate BioScience under which it will receive a defined, exclusive, worldwide license to use the latter’s self-replicating RNA platform to develop... 
Via Stocktwits
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.